Seer to Participate in the Piper Sandler Virtual Healthcare Conference

Rhea-AI Summary

Seer, a life sciences company listed on Nasdaq as SEER, announced its participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference. A pre-recorded presentation will be available online starting November 22, 2021. Additionally, Seer will conduct investor meetings on December 1 and 2, 2021. The company is focused on its Proteograph Product Suite, designed for efficient and deep proteomic analysis, accessible to many laboratories. The suite is for research use only and not intended for diagnostic procedures.

REDWOOD CITY, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will participate in the Piper Sandler 33^rd Annual Virtual Healthcare Conference. A pre-recorded presentation will be available on the conference website beginning on November 22, 2021. A link to the presentation will also be available on the Investors section of the company’s website at investors.seer.bio.

Seer will be participating in investor meetings at the Piper Sandler Healthcare Conference on Wednesday, December 1, 2021 and Thursday, December 2, 2021.

About Seer
Seer™ is a life sciences company developing transformative products that open a new gateway to the proteome. Seer is commercializing its Proteograph™ Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact
Carrie Mendivil
investor@seer.bio

Media Contact
Karen Possemato
pr@seer.bio

FAQ

When will Seer participate in the Piper Sandler Healthcare Conference?

Seer will participate in the Piper Sandler Healthcare Conference on December 1 and 2, 2021.

What is the date of Seer's pre-recorded presentation for the conference?

Seer's pre-recorded presentation will be available starting November 22, 2021.

What platform is Seer commercializing for proteomics?

Seer is commercializing its Proteograph Product Suite, which facilitates deep proteomic analysis.

Is the Proteograph Product Suite intended for diagnostic use?

No, the Proteograph Product Suite is for research use only and is not intended for diagnostic procedures.

Where can I find more information about Seer's investors?

More information about Seer's investor relations can be found on their website at investors.seer.bio.